probiome Sign in
← Conditions Metabolism and nutrition Genus-level

Metabolic syndrome

Compared within 2 studies that had both: 200 people with metabolic syndrome and 330 healthy people. No genera less common in people with metabolic syndrome, and none more common.

A difference is an association: it doesn’t mean these genera cause, prevent or treat metabolic syndrome. GMrepo reports this group at the genus level only, so these are genera, not species.

Searching opens both lists and shows only matching rows.

Less common in metabolic syndrome · 0

Strongest first, then the biggest gap · Each figure is 10 people Strongest first · Each figure is 10 people

None compared.

More common in metabolic syndrome · 0

Strongest first, then the biggest gap · Each figure is 10 people Strongest first · Each figure is 10 people

None compared.

Where these numbers come from

Studies
Only GMrepo projects that had people with the condition and healthy people, 10 or more of each. Numbers come from those studies, never from pooling.Sampled in China, Colombia.
How common
The share of people whose sample has any of it, in the people with the condition and in the healthy people of those same studies. Tested within studies (Cochran–Mantel–Haenszel, corrected for testing many microbes); a difference counts when it is clear and meaningful (Cohen’s h of 0.2 or more).
Strength word
Counted by code from how many studies point the same way: Seen again and again (3 or more, none clearly the other way), Seen more than once (2, the majority), Seen once (1, listed last). Where studies disagree, a row isn’t listed.
Each study
Tap a row for every study’s own numbers, and for how much carriers have.
Analysis
Our analysis of GMrepo data. GMrepo on Data sources · Read the rules

Also compared · 172 genera

Compared within studies that had both, but not listed above.

Studies disagree · 2

No meaningful difference · 170
PubMed · human studies and reviews first

Recent research

All research on it
  1. Review Journal of microbiology and biotechnology · 2026
    Probiotics in Cardiometabolic Diseases: Current Evidence, Postbiotic Perspectives, and Future Directions.
    PubMed ↗
  2. Review Medicina · 2026
    Gut Microbiota in Metabolic Syndrome: Differences in Microbial Signatures and Clinical Profiles.
    PubMed ↗
  3. Randomized trial Nutrients · 2026
    Autoprobiotic Supplements Attenuate Obesity and Improve Gut Microbiota, Carbohydrate, and Lipid Metabolism in Patients with Metabolic Syndrome: A Pilot Trial.
    PubMed ↗
  4. Randomized trial Gut microbes · 2026
    Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels.
    PubMed ↗
  5. Review Minerva endocrinology · 2026
    Gut microbiota and metabolic syndrome in postmenopausal women: a narrative review of mechanisms and dietary recommendations.
    PubMed ↗

Source: PubMed, U.S. National Library of Medicine · 92 linked papers, last 10 years